98 related articles for article (PubMed ID: 8943758)
41. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor.
Tachibana M; Miyakawa A; Tazaki H; Nakamura K; Kubo A; Hata J; Nishi T; Amano Y
Cancer Res; 1995 Aug; 55(15):3438-43. PubMed ID: 7542171
[TBL] [Abstract][Full Text] [Related]
42. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
43. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
Tanikawa S; Nakao I; Tsuneoka K; Nara N
Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphoma: a pilot study for a leukocyte count oriented regimen.
Sawada KI; Sato N; Kohno M; Hannda H; Yasukouchi T; Tanngo M; Hirayama A; Koike T
Leuk Lymphoma; 1995 Dec; 20(1-2):103-9. PubMed ID: 8750630
[TBL] [Abstract][Full Text] [Related]
45. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
46. Endogenous production and peripheral blood levels of granulocyte-macrophage (GM-) and granulocyte (G-) colony-stimulating factors.
Sallerfors B
Leuk Lymphoma; 1994 Apr; 13(3-4):235-47. PubMed ID: 7519508
[TBL] [Abstract][Full Text] [Related]
47. An atypical chronic neutrophilic leukemia patient harboring ASXL1 and NRAS mutations associated with monoclonal plasma cell dyscrasia presenting as hemopericardium.
Han Q; Tao L; Jiang X; Chen H; Liu C; Sun M
Ann Hematol; 2021 Jan; 100(1):273-275. PubMed ID: 32052135
[No Abstract] [Full Text] [Related]
48. Chronic neutrophilic leukaemia: an Egyptian case.
Elbahrawy A; Hamdy M; Morsy MH; Ragab R
BMJ Case Rep; 2009; 2009():. PubMed ID: 21701572
[TBL] [Abstract][Full Text] [Related]
49. Chronic neutrophilic leukemia presenting as secondary gout: Report of a rare myeloproliferative disorder.
; Kakkar N; Joseph John M
Indian J Cancer; 2020; 57(2):201-204. PubMed ID: 32445325
[TBL] [Abstract][Full Text] [Related]
50. Changes in allele frequencies of
Nooruddin Z; Miltgen N; Wei Q; Schowinsky J; Pan Z; Tobin J; Purev E; Gutman JA; Robinson W; Pollyea DA
Haematologica; 2017 May; 102(5):e207-e209. PubMed ID: 28209656
[No Abstract] [Full Text] [Related]
51. Chronic neutrophilic leukemia associated with monoclonal gammopathy of undetermined significance. A multimethod study.
Florensa L; Woessner S; Vicente P; Roig Martí A; Solé F; Pérez A
Ann Hematol; 1993 Sep; 67(3):129-31. PubMed ID: 8373899
[No Abstract] [Full Text] [Related]
52. Plasma Cell Leukaemia: A Rare Yet Aggressive Plasma Cell Dyscrasia With A Very Poor Response To Conventional Therapy.
Khan N; Raza SS; Khan UI; Hafez I; Abdullah MA; Hassan M; Rukh Hijaz AS; Hussain AK; Nadeem MD
J Ayub Med Coll Abbottabad; 2019; 31(2):272-275. PubMed ID: 31094130
[TBL] [Abstract][Full Text] [Related]
53. Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation.
Hinze A; Rinke J; Hochhaus A; Ernst T
Ann Hematol; 2021 Feb; 100(2):581-584. PubMed ID: 32577845
[No Abstract] [Full Text] [Related]
54. Chronic neutrophilic leukemia, a rare case of leukocytosis.
Wang X; Resendes NM; Shanahan L; Hutchinson L; Woda B; Cerny J
Leuk Res; 2020 Jul; 94():106384. PubMed ID: 32447046
[No Abstract] [Full Text] [Related]
55. Granulocyte and platelet adhesiveness in malignant paraproteinaemia, leukaemia and myeloproliferative diseases.
Hopen G
Scand J Haematol; 1981 Nov; 27(5):339-45. PubMed ID: 7346997
[TBL] [Abstract][Full Text] [Related]
56. [Ruxolitinib in the treatment of two cases of chronic neutrophilic leukemia].
Zheng WS; Guan LX; Cheng LC; Hu YL; Xu YY; Yang T; Peng B; Wu YL; Bo J; Wang QS; Gao XN
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):113-114. PubMed ID: 32135644
[No Abstract] [Full Text] [Related]
57. [Pathological studies of chronic neutrophilic leukaemia involving skin].
Wang K; Shao QY; Cao PL; Wang CB; Wang HY
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):837-839. PubMed ID: 32746553
[No Abstract] [Full Text] [Related]
58. Granulocyte-colony stimulating factor- and interleukin-1β-positive cardiac myxoma accompanying neutrophilic dermatosis.
Ajiro Y; Nino H; Ueda T; Bonkohara Y
JTCVS Tech; 2020 Mar; 1():69-71. PubMed ID: 34317719
[No Abstract] [Full Text] [Related]
59. Multiple myeloma with G-CSF production mimicking chronic neutrophilic leukemia.
Ureshino H; Ohshima K; Miyahara M
EJHaem; 2021 May; 2(2):299-300. PubMed ID: 35845287
[No Abstract] [Full Text] [Related]
60. When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.
Willekens C; Chahine C; Dragani M; Khalife-Hachem S; Bigenwald C; Rossignol J; Castilla-Llorente C; Danu A; Michot JM; Saada V; Cotteret S; Marzac C; Renneville A; Plo I; Broutin S; Bosselut N; Cassinat B; Lazarovici J; Droin N; De Botton S
EJHaem; 2023 Aug; 4(3):823-826. PubMed ID: 37601857
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
